221 related articles for article (PubMed ID: 19054791)
1. A humanized anti-M2 scFv shows protective in vitro activity against influenza.
Gabbard J; Velappan N; Di Niro R; Schmidt J; Jones CA; Tompkins SM; Bradbury AR
Protein Eng Des Sel; 2009 Mar; 22(3):189-98. PubMed ID: 19054791
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein.
Wang R; Song A; Levin J; Dennis D; Zhang NJ; Yoshida H; Koriazova L; Madura L; Shapiro L; Matsumoto A; Yoshida H; Mikayama T; Kubo RT; Sarawar S; Cheroutre H; Kato S
Antiviral Res; 2008 Nov; 80(2):168-77. PubMed ID: 18598723
[TBL] [Abstract][Full Text] [Related]
3. Fine specificity and sequence of antibodies directed against the ectodomain of matrix protein 2 of influenza A virus.
Zhang M; Zharikova D; Mozdzanowska K; Otvos L; Gerhard W
Mol Immunol; 2006 Jul; 43(14):2195-206. PubMed ID: 16472860
[TBL] [Abstract][Full Text] [Related]
4. Human single chain monoclonal antibody that recognizes matrix protein of heterologous influenza A virus subtypes.
Poungpair O; Chaicumpa W; Kulkeaw K; Maneewatch S; Thueng-in K; Srimanote P; Tongtawe P; Songserm T; Lekcharoensuk P; Tapchaisri P
J Virol Methods; 2009 Jul; 159(1):105-11. PubMed ID: 19442853
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies recognizing EVETPIRN epitope of influenza A virus M2 protein could protect mice from lethal influenza A virus challenge.
Liu W; Zou P; Chen YH
Immunol Lett; 2004 May; 93(2-3):131-6. PubMed ID: 15158608
[TBL] [Abstract][Full Text] [Related]
6. Humanization of agonistic anti-human 4-1BB monoclonal antibody using a phage-displayed combinatorial library.
Son JH; Lee UH; Lee JJ; Kwon B; Kwon BS; Park JW
J Immunol Methods; 2004 Mar; 286(1-2):187-201. PubMed ID: 15087232
[TBL] [Abstract][Full Text] [Related]
7. Effects of antibody to the influenza A virus M2 protein on M2 surface expression and virus assembly.
Hughey PG; Roberts PC; Holsinger LJ; Zebedee SL; Lamb RA; Compans RW
Virology; 1995 Oct; 212(2):411-21. PubMed ID: 7571410
[TBL] [Abstract][Full Text] [Related]
8. Characterizations of four monoclonal antibodies against M2 protein ectodomain of influenza A virus.
Fu TM; Freed DC; Horton MS; Fan J; Citron MP; Joyce JG; Garsky VM; Casimiro DR; Zhao Q; Shiver JW; Liang X
Virology; 2009 Mar; 385(1):218-26. PubMed ID: 19070878
[TBL] [Abstract][Full Text] [Related]
9. Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.
Villani ME; Morea V; Consalvi V; Chiaraluce R; Desiderio A; Benvenuto E; Donini M
Mol Immunol; 2008 May; 45(9):2474-85. PubMed ID: 18313757
[TBL] [Abstract][Full Text] [Related]
10. Treatment of influenza virus-infected SCID mice with nonneutralizing antibodies specific for the transmembrane proteins matrix 2 and neuraminidase reduces the pulmonary virus titer but fails to clear the infection.
Mozdzanowska K; Maiese K; Furchner M; Gerhard W
Virology; 1999 Feb; 254(1):138-46. PubMed ID: 9927581
[TBL] [Abstract][Full Text] [Related]
11. Monovalent single-chain Fv fragments and bivalent miniantibodies bound to vesicular stomatitis virus protect against lethal infection.
Kalinke U; Krebber A; Krebber C; Bucher E; Plückthun A; Zinkernagel RM; Hengartner H
Eur J Immunol; 1996 Dec; 26(12):2801-6. PubMed ID: 8977271
[TBL] [Abstract][Full Text] [Related]
12. Cloning and expression of functional single-chain Fv antibodies directed against NIa and coat proteins of potato virus Y.
Rouis S; Lafaye P; Jaoua-Aydi L; Sghaier Z; Ayadi H; Gargouri-Bouzid R
J Virol Methods; 2006 Oct; 137(1):1-6. PubMed ID: 16884787
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody recognizing SLLTEVET epitope of M2 protein potently inhibited the replication of influenza A viruses in MDCK cells.
Wang Y; Zhou L; Shi H; Xu H; Yao H; Xi XG; Toyoda T; Wang X; Wang T
Biochem Biophys Res Commun; 2009 Jul; 385(1):118-22. PubMed ID: 19410554
[TBL] [Abstract][Full Text] [Related]
14. Modulation of Epstein-Barr virus latent membrane protein 1 activity by intrabodies.
Fang CY; Chiang CY; Pan YR; Tse KP; Chang YS; Chang HY
Intervirology; 2007; 50(4):254-63. PubMed ID: 17460414
[TBL] [Abstract][Full Text] [Related]
15. The epitope recognized by a monoclonal antibody in influenza A virus M2 protein is immunogenic and confers immune protection.
Zou P; Liu W; Chen YH
Int Immunopharmacol; 2005 Apr; 5(4):631-5. PubMed ID: 15710332
[TBL] [Abstract][Full Text] [Related]
16. The antibody responses to swine influenza virus (SIV) recombinant matrix 1 (rM1), matrix 2 (M2), and hemagglutinin (HA) proteins in pigs with different SIV exposure.
Kitikoon P; Strait EL; Thacker EL
Vet Microbiol; 2008 Jan; 126(1-3):51-62. PubMed ID: 17719187
[TBL] [Abstract][Full Text] [Related]
17. Chimeric antibodies against tick-borne encephalitis virus.
Levanov LN; Matveev LE; Goncharova EP; Lebedev LR; Ryzhikov AB; Yun TE; Batanova TA; Shvalov AN; Baykov IK; Shingarova LN; Kirpichnikov MP; Tikunova NV
Vaccine; 2010 Jul; 28(32):5265-71. PubMed ID: 20538092
[TBL] [Abstract][Full Text] [Related]
18. Preparation of monoclonal antibodies against poor immunogenic avian influenza virus proteins.
He JL; Hsieh MS; Chiu YC; Juang RH; Wang CH
J Immunol Methods; 2013 Jan; 387(1-2):43-50. PubMed ID: 23022629
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibody, but not synthetic peptide, targeting the ectodomain of influenza B virus M2 proton channel has antiviral activity.
Wang Y; Xu H; Wu N; Shi H; Wang X; Wang T
New Microbiol; 2010 Oct; 33(4):311-7. PubMed ID: 21213589
[TBL] [Abstract][Full Text] [Related]
20. Humanization of high affinity anti-HBs antibody by using human consensus sequence and modification of selected minimal positional template and packing residues.
Tiwari A; Khanna N; Acharya SK; Sinha S
Vaccine; 2009 Apr; 27(17):2356-66. PubMed ID: 19428851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
